For years people have been discussing the issue of whether Tattoos can cause cancer. The worry was first sparked when someone was arrested for driving with a tattoo on their arm. Later reports came out that the person had gotten the tattoo because it looked good on him. With more concern being expressed about whether Tattoos can cause cancer or not, more medical professionals are starting to pay more attention to the topic. There are even articles being written about it now.
So what exactly can cause the risk of getting skin cancer? Well, there are several things that can go into it. Many people who get tattoos are doing it because they are looking for that perfect piece of art that will symbolize their individuality; however, the risks of getting skin cancer can be increased by certain tattoos in the early stages. However, recent studies that have discovered the inks containing a host of dangerous chemicals, such as lead, phthalates, and hydrocarbon brittanides, which are all known carcinogens, have shown that in the early stages of cancer development, the inks actually cause more harm than good.
One particular case study involved a sixty-year-old man who was a former patient of radiation therapy who developed non-Hodgkins lymphoma, a type of cancer, after having a complete breast reconstruction. The medical professor that was doing the clinical investigation of the man noticed that at the early stages of cancer, his lymph nodes contained undigested beta-amyloid plaque. A medical expert who did an analysis of the medical records concluded that the man probably contracted beta-amyloid plaque from being implanted with a human implantable sarcomatoid. After the implantation, the medical professor noted that the plaque settled into the soft tissue of the body, where it remained until it eventually became cancerous.
This story is just one of many documented cases of late-stage cancer contracting from an implanted object, including one in the case of a seventy-year-old woman who was suffering from pancreatic cancer and had been recently treated for radiation. Although the woman was told by her physician that she did not have pancreatic cancer, imaging tests later revealed a small pancreatic tumor, which was surgically removed. Another case involved a thirty-year-old man who was suffering from a ruptured ovarian cyst. During an imaging study, the medical professor noticed that the cyst was filled with a hard pink fluid, which he determined was rich in calcium and likely contained living cells.
After the medical practitioner diagnosed the tumor, the woman and her husband sought the services of a well-known stomatologist, Dr. Milton Zaltman. It was reported that Dr. Zaltman had previously treated numerous patients with lecithin, an essential fatty acid found in oily fish such as tuna and mackerel, which has been shown to inhibit cancer growth. The couple was excited when they learned that Dr. Zaltman had recently discovered that he could use imaging contrast agents to identify the cancerous areas of the body without surgical biopsies or any other invasive technique. Dr. Zaltman used an imaging contrast agent called quantum light emission tomography (or QUID) to determine whether or not their wife’s lump was benign, which is quite different from doing a biopsy. Based on the imaging contrast agent, the doctor was able to correctly diagnose cancer and recommended that the patient undergo chemotherapy.
Although the patient had not yet received the chemotherapy she needed, she was excited when she learned that her cancer was being matched against a wide variety of other forms. The medical professor explained to her husband that some cancers were simply different kinds of skin cancers and that the two weren’t related. The professor went on to say that he was testing several different nanoparticles against the specific kind of cancer that he was testing. One of the nanoparticles was matching dyes that were found in her wife’s tumor. She was ecstatic when she heard this and began planning her treatment accordingly.
When it was determined that Zaltman’s method was indeed accurate and that the specific dyes did in fact match the nanotechnology in her tumor, then she could proceed with her plan. However, one problem that remained was whether it would be feasible to administer the contrast agents through Tattoos. It was discovered that Zaltman’s research team had recently received approval for a new method of using a low dose of contrast agents in combination with tattooing. The solution was to have the scientists create a special liposome-like structure that would be inserted into the woman’s body under a minimal amount of pain. Once inserted, the liposome would break up the cancerous cells and allow the woman to survive her treatment.
Unfortunately, it was discovered that the liposome was not good enough and that it required further development. However, they were able to fine-tune the liposome using scanning technology and to make it compatible with several different kinds of imaging modalities. This allowed the imaging team to develop an imaging system that combined high-resolution x-rays, magnetic resonance imaging, optical scanning, and PET imaging to yield excellent images of the pancreatic tumor. Furthermore, they were able to combine the pancreatic tumor imaging with a minimally invasive procedure that relied on magnetic resonance contrast agents to kill cancer cells without harming healthy tissue.